Shayna Korol, —
Articles by
Recent Posts
- Study: Little understanding impacts patient quality of life in Fabry
- How I’m working to mitigate the risk of stroke with Fabry disease
- Less frequent Elfabrio ERT regimen for Fabry up for EU approval
- Fabry gene therapy EXG110 granted FDA’s orphan drug status
- Molecular fingerprint shows potential to spot Fabry in either sex
- Long-term ERT normalizes Fabry inflammation, oxidative stress
- Boy with Fabry disease diagnosed with co-occurring blood disorder
- Teva’s Galafold generic for Fabry disease may be available in US
- Less frequent Elfabrio dosing for Fabry disease appears safe, effective
- Fabry disease can’t dampen the adventurous spirit of my kids